Emerald Health Therapeutics to Participate in Cowen 2nd Annual Boston Cannabis Conference
October 31, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) will participate in the Cowen 2nd Annual Boston Cannabis...
Emerald Health Therapeutics Reports First Quarter 2019 Financial Results; Demonstrates Continued Growth in Sales
May 31, 2019 08:32 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, May 31, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today reported financial results for the quarter ended March 31,...
Emerald Health Therapeutics to Participate in Cowen Toronto Cannabis Summit
May 15, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, May 15, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) will participate in Cowen’s Toronto Cannabis Summit on May 22 in...
Emerald Health Therapeutics Closes $10.8 Million Prospectus Sale
December 07, 2018 18:11 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) ("Emerald" or the “Company”) closed today its prospectus sale (the “Offering”)...
SiTime Launches the Emerald Platform, a Game-changing MEMS Timing Solution for 5G Infrastructure
November 05, 2018 08:00 ET
|
SiTime
Enables 5G Equipment to be Deployed Anywhere, in Any Environment Solves critical timing challenges for 5G infrastructureSets new performance benchmarks–20 times better–in the $1.5 billion telecom...
Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update
August 30, 2018 12:35 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald” or “the Company”) has filed its financial statements and management...
Emerald Health Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
August 28, 2018 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that Chris Wagner, Chief Executive Officer, will...
Emerald Health Therapeutics Reports 1st Quarter 2018 Financial Results and Provides Corporate Update
May 29, 2018 08:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, May 29, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V:EMH) (OTCQX:EMHTF) (“Emerald” or “the Company”) has filed its financial statements and...
Emerald Health Therapeutics Acquires Cannabis Licensed Producer in Québec
May 02, 2018 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, May 02, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH) (OTCQX:EMHTF) (Frankfurt:TBD) announced today that it has acquired (the...
Emerald Health Therapeutics Names DDB Canada Agency of Record
April 20, 2018 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, April 20, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc. (“Emerald”) (TSX-V:EMH) (OTCQX:EMHTF) today announced DDB Canada’s Vancouver office its agency of...